Astrana Health names new principal accounting officer

Astrana Health, Inc. announced that Chief Accounting Officer and principal accounting officer Glenn Sobotka will retire from his positions effective August 7, 2026.

Rhea-AI Filing Summary

Astrana Health, Inc. announced that Chief Accounting Officer and principal accounting officer Glenn Sobotka will retire from his positions effective August 7, 2026. The company states his retirement is not due to any disagreement regarding operations, policies, or practices.

John Vong, currently Group Vice President, Accounting, has been appointed Senior Vice President – Accounting effective July 1, 2026 and will become principal accounting officer on August 7, 2026. Vong, age 52, has extensive prior experience in senior accounting roles at Astrana Health and Prospect Medical Systems. Effective July 1, 2026, his annual base salary will be $320,000. The company notes there are no related-party transactions or family relationships requiring disclosure.

Insights

Corporate governance analyst

Planned accounting leadership transition with an internal successor looks orderly.

Astrana Health outlines a scheduled handover of the principal accounting officer role, with Glenn Sobotka retiring in early August 2026. The company stresses there is no disagreement driving his departure, which helps reduce concern about underlying issues.

The incoming principal accounting officer, John Vong, has held multiple senior accounting roles at Astrana Health since 2022, plus prior experience at Prospect Medical Systems. This internal promotion suggests continuity in financial reporting processes. His new base salary of $320,000 aligns with elevated responsibilities, while his target bonus terms remain unchanged.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Retirement effective date: August 7, 2026 New role effective date: July 1, 2026 Annual base salary: $320,000 +1 more

4 metrics

Retirement effective date August 7, 2026 Effective date of Glenn Sobotka’s retirement

New role effective date July 1, 2026 Effective date of John Vong’s SVP – Accounting role

Annual base salary $320,000 John Vong’s base salary effective July 1, 2026

Executive age 52 Age of incoming principal accounting officer John Vong

Key Terms

principal accounting officer, Senior Vice President – Accounting, emerging growth company, Item 404(a) of Regulation S-K

4 terms

principal accounting officer financial

"will succeed Mr. Sobotka as the Company’s principal accounting officer, effective as of August 7, 2026"

The Principal Accounting Officer is the person responsible for making sure a company's financial records are accurate and follow the rules. They play a key role in preparing financial reports that show how well the company is doing. This helps investors, managers, and regulators trust the company's financial information.

Senior Vice President – Accounting financial

"John Vong, who has been appointed as Senior Vice President – Accounting effective July 1, 2026"

emerging growth company regulatory

"Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Item 404(a) of Regulation S-K regulatory

"no transactions to which the Company is a party and in which Mr. Vong has a direct or indirect material interest that would be required to be disclosed under Item 404(a) of Regulation S-K"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What leadership change did Astrana Health (ASTH) disclose in this 8-K?

Astrana Health disclosed that Chief Accounting Officer Glenn Sobotka will retire effective August 7, 2026. Senior Vice President – Accounting, John Vong, will assume the role of principal accounting officer on the same date, providing an internal succession plan for the company’s top accounting position.

When will Astrana Health’s current Chief Accounting Officer retire?

Glenn Sobotka will retire from his roles as Chief Accounting Officer and principal accounting officer effective August 7, 2026. The company states his retirement is not due to any disagreement about its operations, policies, or practices, indicating an orderly, planned transition.

Who is replacing the retiring principal accounting officer at Astrana Health (ASTH)?

Senior Vice President – Accounting, John Vong, will become Astrana Health’s principal accounting officer on August 7, 2026. He has held several senior accounting roles at the company since 2022 and previously served as Chief Accounting Officer, bringing continuity and experience to the position.

What is the new base salary for Astrana Health executive John Vong?

Effective July 1, 2026, John Vong’s annual base salary will be $320,000. This adjustment reflects his promotion to Senior Vice President – Accounting and upcoming role as principal accounting officer while his 2026 target bonus opportunity percentage remains unchanged under his existing employment agreement.

Did Astrana Health report any disagreements related to the accounting officer’s retirement?

Astrana Health states that Glenn Sobotka’s retirement is not the result of any disagreement with the company. This includes matters relating to operations, policies, or practices, suggesting the change is a routine leadership transition rather than a response to internal disputes or reporting issues.

Are there any related-party or family relationships involving John Vong at Astrana Health?

The company reports no arrangements or understandings with other persons regarding John Vong’s selection. It also states there are no family relationships with directors or executive officers and no Item 404(a) Regulation S-K transactions in which he has a material interest requiring disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 04:15 PM Learn about SEC filing dates

false 0001083446 0001083446 2026-06-25 2026-06-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): June 25, 2026

ASTRANA HEALTH, INC.

(Exact Name of Registrant as Specified in Charter)

Delaware	001-37392	95-4472349
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation)	File Number)	Identification No.)

1668 S. Garfield Avenue, 2nd Floor, Alhambra, California 91801

(Address of Principal Executive Offices) (Zip Code)

(626) 282-0288

Registrant’s Telephone Number, Including Area Code

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value per share	ASTH	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 25, 2026, Glenn Sobotka, the Chief Accounting Officer and principal accounting officer of Astrana Health, Inc. (the “Company”), and the Company agreed that Mr. Sobotka will retire from his positions with the Company effective as of August 7, 2026. Mr. Sobotka’s retirement is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.

John Vong, who has been appointed as Senior Vice President – Accounting effective July 1, 2026, will succeed Mr. Sobotka as the Company’s principal accounting officer, effective as of August 7, 2026. Mr. Vong, 52, has previously served as the Company’s Group Vice President, Accounting since March 2025. Prior to that, Mr. Vong served as the Company’s Chief Accounting Officer and principal accounting officer from November 2022 to March 2025 and as its Vice President of Finance and Accounting from July 2022 to November 2022. Prior to joining the Company, Mr. Vong served as Vice President of Finance and Accounting at Prospect Medical Systems, Inc. from February 2016 to July 2022. Mr. Vong began his career as a certified public accountant with RSM. Mr. Vong received a Bachelor of Science degree in Business Administration from the University of California, Riverside and a Master of Business Administration degree from the University of California, Irvine.

Effective as of July 1, 2026, Mr. Vong’s annual base salary will increase to $320,000. Mr. Vong’s target bonus opportunity as a percentage of his annual base salary for 2026 pursuant to his employee agreement remains unchanged.

There is no arrangement or understanding between Mr. Vong or any other person pursuant to which he was selected as principal accounting officer of the Company, and there are no family relationships between Mr. Vong and any of the Company’s directors or executive officers. There are no transactions to which the Company is a party and in which Mr. Vong has a direct or indirect material interest that would be required to be disclosed under Item 404(a) of Regulation S-K.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ASTRANA HEALTH, INC.
Date: July 1, 2026	By:	/s/ Brandon K. Sim
	Name:	Brandon K. Sim
	Title:	Chief Executive Officer and President

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 2.9 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 33.4 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 21.8 KB